For study descriptions, see the ClinicalTrials.gov Identifier (NCT Number):
Attention Deficit Hyperactivity Disorder
- Multimodal Treatment Study of Children with Attention Deficit and Hyperactivity Disorder (MTA) (NCT00000388)External Link: Please review our disclaimer.
Alzheimer's Disease
- Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): in Patients with Alzheimer’s Disease (NCT00015548)External Link: Please review our disclaimer.
Anxiety Disorders
- Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes* (NCT00347269)External Link: Please review our disclaimer.
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Treatment For Anxiety in Children (NCT00000389)External Link: Please review our disclaimer.
Autism Spectrum Disorder
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Treatment of Autism in Children and Adolescents (NCT00005014)External Link: Please review our disclaimer.
Bipolar Disorder
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)* (NCT00012558)External Link: Please review our disclaimer.
- Treatment of Early Age Mania (TEAM) (NCT00057681)External Link: Please review our disclaimer.
Depression
- Combining Medications to Enhance Depression Outcomes (CO-MED)* (NCT00590863)External Link: Please review our disclaimer.
- Research Evaluating the Value of Augmenting Medication With Psychotherapy (REVAMP) (NCT00057551)External Link: Please review our disclaimer.
- Sequenced Treatment Alternatives to Relieve Depression (STAR*D)* (NCT00021528)External Link: Please review our disclaimer.
- Treatment for Adolescents with Depression Study (TADS)/Substance Use and Other Outcomes Following Treatment for Adolescent Depression (SOFTAD)* (NCT00006286)External Link: Please review our disclaimer.
- Treatment of Major Depression with St. John's Wort (Hypericum) (NCT00005013)External Link: Please review our disclaimer.
- Treatment of SSRI-Resistant Depression In Adolescents (TORDIA) (NCT00018902)External Link: Please review our disclaimer.
Pervasive Developmental Disorder
- Research Units in Pediatric Psychopharmacology (RUPP) Studies: Methylphenidate in Children and Adolescents With Pervasive Development Disorders (NCT00025779)External Link: Please review our disclaimer.
Schizophrenia
- Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Schizophrenia* (NCT00014001)External Link: Please review our disclaimer.
- Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) (NCT00816907)External Link: Please review our disclaimer.
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE) (NCT00330863)External Link: Please review our disclaimer.
Procedures for Requesting Limited Access Datasets
Investigators wishing to request any of the above datasets must obtain and submit a Data Use Certificate (DUC) in order for NIMH to release the dataset. Please note that the DUC requires the institution's Federal Wide Assurance (FWA) number and the signature of the institution's official.
To request a DUC, send an email to: nimhdatasets@mail.nih.gov. Be sure to specify the dataset that you are requesting.
*NOTE: Trials marked with an asterisk also collected genetics-related biomaterials from willing participants. The biomaterial, genetics data, and companion clinical data for those participants are available from the NIMH Center for Collaborative Genetic StudiesExternal Link: Please review our disclaimer. and may be requested under the Center’s Distribution AgreementExternal Link: Please review our disclaimer.. These genetics data and companion clinical data are not available from the NIMH Clinical Trials Limited Access Datasets office.
